Sciatica — supplement protocol and what to skip
Sciatica is radiating leg pain from sciatic-nerve-root irritation, most often caused by a lumbar disc herniation or spinal stenosis. The mainstay interventions are physical therapy with a directional-preference component (McKenzie or equivalent), graded activity, short courses of NSAIDs where safe, and — in selected cases — epidural steroid injection or surgery. Supplements are adjuncts: they support nerve-recovery biology and reduce systemic inflammation modestly, but they do not replace mechanical and rehabilitative care.
Supplements with credible adjunctive evidence
Vitamin B12 (methylcobalamin)
500–1500 mcg methylcobalamin daily for 8–12 weeks
Methylcobalamin has been studied in radicular and peripheral neuropathic pain. Trials (largely from Asian centres) at 1500 mcg/day show modest pain and nerve-conduction improvement. The form matters — methylcobalamin or hydroxocobalamin, not cyanocobalamin — for the neuropathic indication. Test serum B12 first; baseline deficiency makes the case stronger.
Alpha-lipoic acid
600 mg/day, with food
ALA has the cleanest trial record in diabetic peripheral neuropathy at 600 mg/day; the radicular-pain trial base is smaller but suggests modest benefit at the same dose. Acts as a mitochondrial cofactor and recycles other antioxidants. Avoid with anticoagulants without monitoring (mild antiplatelet effect).
Magnesium glycinate
300–400 mg elemental magnesium at bedtime
Magnesium has muscle-relaxant and analgesic activity at therapeutic doses; small trials in chronic low back pain at intravenous (and oral) doses show modest pain reduction. The glycinate form is well tolerated. Indirect benefit through improved sleep quality, which itself reduces pain perception.
Omega-3 (EPA/DHA)
1.5–3 g combined EPA + DHA daily
Omega-3 reduces inflammatory mediators (PGE2, leukotrienes) and has modest analgesic effects in inflammatory pain. The radicular-pain trial base is small but a 2006 Maroon pilot trial in chronic neck and back pain showed pain reduction at high doses. Pause 1 week before any planned epidural or surgical intervention.
Curcumin (bioavailable form)
500 mg twice daily of a phospholipid or piperine-enhanced formulation
Bioavailable curcumin (Meriva, BCM-95, or piperine-paired) has musculoskeletal-pain trials showing efficacy comparable to ibuprofen at 1000 mg/day. Particularly useful when chronic NSAID use is not feasible (GI, renal, or cardiovascular contraindications). Pause 1–2 weeks pre-surgery (antiplatelet activity).
What to skip
- "Nerve regeneration" stacks built around PEA or palmitoylethanolamide at low marketed doses — the trial doses (600–1200 mg/day micronised) are higher than most products deliver, and the radiculopathy-specific data is mixed.
- Glucosamine and chondroitin for sciatica — useful in knee osteoarthritis, irrelevant to radicular nerve pain.
- "Inflammation gummies" with proprietary blends — sub-therapeutic doses of multiple ingredients; verify each component at trial dose if you want the effect.
- High-dose vitamin B6 (>100 mg/day) chronically — paradoxically can cause sensory neuropathy. Total daily B6 from all sources should stay under 100 mg.
- CBD as monotherapy — modest evidence in some chronic-pain contexts, but the radicular-pain trial data is essentially absent, and product quality varies widely.
Sources
- Zhang M, et al. Methylcobalamin for the treatment of subacute herpes zoster–associated pain: a randomized clinical trial. Pain Med. 2018;19(7):1377–1384. PMID: 29045743
- Ziegler D, et al. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care. 2011;34(9):2054–2060. PMID: 21775755
- Maroon JC, Bost JW. Omega-3 fatty acids (fish oil) as an anti-inflammatory: an alternative to nonsteroidal anti-inflammatory drugs for discogenic pain. Surg Neurol. 2006;65(4):326–331. PMID: 16531187
- Belcaro G, et al. Efficacy and safety of Meriva, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev. 2010;15(4):337–344. PMID: 21194249
- Yousef AAA-M, Al-deeb AE. A double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component. Anaesthesia. 2013;68(3):260–266. PMID: 23316752
- Konstantinou K, Dunn KM. Sciatica: review of epidemiological studies and prevalence estimates. Spine. 2008;33(22):2464–2472. PMID: 18923325